Metagenomic analysis of the fecal microbiome in colorectal cancer patients compared to healthy controls as a function of age
Abstract Background and Aims Colorectal cancer (CRC) incidence is increasing in young patients without a clear etiology. Emerging data have implicated the fecal microbiome in CRC carcinogenesis. However, its impact on young onset CRC is poorly defined. Methods We performed a meta‐analysis of fecal m...
Main Authors: | Jordan Kharofa, Senu Apewokin, Theresa Alenghat, Nicholas J. Ollberding |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-02-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.5197 |
Similar Items
-
Gut Microbiome and Colorectal Cancer
by: Tae-Geun Gweon
Published: (2023-08-01) -
Fecal Fusobacterium nucleatum for the diagnosis of colorectal tumor: A systematic review and meta‐analysis
by: Xinyu Zhang, et al.
Published: (2019-02-01) -
Fusobacterium nucleatum Abundance is Associated with Cachexia in Colorectal Cancer Patients: The ColoCare Study
by: Mmadili N. Ilozumba, et al.
Published: (2024-11-01) -
Metformin elicits antitumour effect by modulation of the gut microbiota and rescues Fusobacterium nucleatum-induced colorectal tumourigenesis
by: Xiaowen Huang, et al.
Published: (2020-11-01) -
Metagenomics analysis reveals universal signatures of the intestinal microbiota in colorectal cancer, regardless of regional differences
by: L. Berbert, et al.
Published: (2022-03-01)